Artificial Intelligence-driven Drug Development Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Artificial Intelligence-driven Drug Development
1.2 Key Market Segments
1.2.1 Artificial Intelligence-driven Drug Development Segment by Type
1.2.2 Artificial Intelligence-driven Drug Development Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Artificial Intelligence-driven Drug Development Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Artificial Intelligence-driven Drug Development Market Competitive Landscape
3.1 Global Artificial Intelligence-driven Drug Development Revenue Market Share by Company (2019-2024)
3.2 Artificial Intelligence-driven Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Artificial Intelligence-driven Drug Development Market Size Sites, Area Served, Product Type
3.4 Artificial Intelligence-driven Drug Development Market Competitive Situation and Trends
3.4.1 Artificial Intelligence-driven Drug Development Market Concentration Rate
3.4.2 Global 5 and 10 Largest Artificial Intelligence-driven Drug Development Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Artificial Intelligence-driven Drug Development Value Chain Analysis
4.1 Artificial Intelligence-driven Drug Development Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Artificial Intelligence-driven Drug Development Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Artificial Intelligence-driven Drug Development Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2019-2024)
6.3 Global Artificial Intelligence-driven Drug Development Market Size Growth Rate by Type (2019-2024)
7 Artificial Intelligence-driven Drug Development Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Artificial Intelligence-driven Drug Development Market Size (M USD) by Application (2019-2024)
7.3 Global Artificial Intelligence-driven Drug Development Market Size Growth Rate by Application (2019-2024)
8 Artificial Intelligence-driven Drug Development Market Segmentation by Region
8.1 Global Artificial Intelligence-driven Drug Development Market Size by Region
8.1.1 Global Artificial Intelligence-driven Drug Development Market Size by Region
8.1.2 Global Artificial Intelligence-driven Drug Development Market Size Market Share by Region
8.2 North America
8.2.1 North America Artificial Intelligence-driven Drug Development Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Artificial Intelligence-driven Drug Development Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Artificial Intelligence-driven Drug Development Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Artificial Intelligence-driven Drug Development Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Artificial Intelligence-driven Drug Development Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 IBM
9.1.1 IBM Artificial Intelligence-driven Drug Development Basic Information
9.1.2 IBM Artificial Intelligence-driven Drug Development Product Overview
9.1.3 IBM Artificial Intelligence-driven Drug Development Product Market Performance
9.1.4 IBM Artificial Intelligence-driven Drug Development SWOT Analysis
9.1.5 IBM Business Overview
9.1.6 IBM Recent Developments
9.2 Exscientia
9.2.1 Exscientia Artificial Intelligence-driven Drug Development Basic Information
9.2.2 Exscientia Artificial Intelligence-driven Drug Development Product Overview
9.2.3 Exscientia Artificial Intelligence-driven Drug Development Product Market Performance
9.2.4 IBM Artificial Intelligence-driven Drug Development SWOT Analysis
9.2.5 Exscientia Business Overview
9.2.6 Exscientia Recent Developments
9.3 Google(Alphabet)
9.3.1 Google(Alphabet) Artificial Intelligence-driven Drug Development Basic Information
9.3.2 Google(Alphabet) Artificial Intelligence-driven Drug Development Product Overview
9.3.3 Google(Alphabet) Artificial Intelligence-driven Drug Development Product Market Performance
9.3.4 IBM Artificial Intelligence-driven Drug Development SWOT Analysis
9.3.5 Google(Alphabet) Business Overview
9.3.6 Google(Alphabet) Recent Developments
9.4 Microsoft
9.4.1 Microsoft Artificial Intelligence-driven Drug Development Basic Information
9.4.2 Microsoft Artificial Intelligence-driven Drug Development Product Overview
9.4.3 Microsoft Artificial Intelligence-driven Drug Development Product Market Performance
9.4.4 Microsoft Business Overview
9.4.5 Microsoft Recent Developments
9.5 Atomwise
9.5.1 Atomwise Artificial Intelligence-driven Drug Development Basic Information
9.5.2 Atomwise Artificial Intelligence-driven Drug Development Product Overview
9.5.3 Atomwise Artificial Intelligence-driven Drug Development Product Market Performance
9.5.4 Atomwise Business Overview
9.5.5 Atomwise Recent Developments
9.6 Schrodinger
9.6.1 Schrodinger Artificial Intelligence-driven Drug Development Basic Information
9.6.2 Schrodinger Artificial Intelligence-driven Drug Development Product Overview
9.6.3 Schrodinger Artificial Intelligence-driven Drug Development Product Market Performance
9.6.4 Schrodinger Business Overview
9.6.5 Schrodinger Recent Developments
9.7 Aitia
9.7.1 Aitia Artificial Intelligence-driven Drug Development Basic Information
9.7.2 Aitia Artificial Intelligence-driven Drug Development Product Overview
9.7.3 Aitia Artificial Intelligence-driven Drug Development Product Market Performance
9.7.4 Aitia Business Overview
9.7.5 Aitia Recent Developments
9.8 Insilico Medicine
9.8.1 Insilico Medicine Artificial Intelligence-driven Drug Development Basic Information
9.8.2 Insilico Medicine Artificial Intelligence-driven Drug Development Product Overview
9.8.3 Insilico Medicine Artificial Intelligence-driven Drug Development Product Market Performance
9.8.4 Insilico Medicine Business Overview
9.8.5 Insilico Medicine Recent Developments
9.9 NVIDIA
9.9.1 NVIDIA Artificial Intelligence-driven Drug Development Basic Information
9.9.2 NVIDIA Artificial Intelligence-driven Drug Development Product Overview
9.9.3 NVIDIA Artificial Intelligence-driven Drug Development Product Market Performance
9.9.4 NVIDIA Business Overview
9.9.5 NVIDIA Recent Developments
9.10 XtalPi
9.10.1 XtalPi Artificial Intelligence-driven Drug Development Basic Information
9.10.2 XtalPi Artificial Intelligence-driven Drug Development Product Overview
9.10.3 XtalPi Artificial Intelligence-driven Drug Development Product Market Performance
9.10.4 XtalPi Business Overview
9.10.5 XtalPi Recent Developments
9.11 BPGbio
9.11.1 BPGbio Artificial Intelligence-driven Drug Development Basic Information
9.11.2 BPGbio Artificial Intelligence-driven Drug Development Product Overview
9.11.3 BPGbio Artificial Intelligence-driven Drug Development Product Market Performance
9.11.4 BPGbio Business Overview
9.11.5 BPGbio Recent Developments
9.12 Owkin
9.12.1 Owkin Artificial Intelligence-driven Drug Development Basic Information
9.12.2 Owkin Artificial Intelligence-driven Drug Development Product Overview
9.12.3 Owkin Artificial Intelligence-driven Drug Development Product Market Performance
9.12.4 Owkin Business Overview
9.12.5 Owkin Recent Developments
9.13 CytoReason
9.13.1 CytoReason Artificial Intelligence-driven Drug Development Basic Information
9.13.2 CytoReason Artificial Intelligence-driven Drug Development Product Overview
9.13.3 CytoReason Artificial Intelligence-driven Drug Development Product Market Performance
9.13.4 CytoReason Business Overview
9.13.5 CytoReason Recent Developments
9.14 Deep Genomics
9.14.1 Deep Genomics Artificial Intelligence-driven Drug Development Basic Information
9.14.2 Deep Genomics Artificial Intelligence-driven Drug Development Product Overview
9.14.3 Deep Genomics Artificial Intelligence-driven Drug Development Product Market Performance
9.14.4 Deep Genomics Business Overview
9.14.5 Deep Genomics Recent Developments
9.15 Cloud Pharmaceuticals
9.15.1 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Basic Information
9.15.2 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Product Overview
9.15.3 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Product Market Performance
9.15.4 Cloud Pharmaceuticals Business Overview
9.15.5 Cloud Pharmaceuticals Recent Developments
9.16 BenevolentAI
9.16.1 BenevolentAI Artificial Intelligence-driven Drug Development Basic Information
9.16.2 BenevolentAI Artificial Intelligence-driven Drug Development Product Overview
9.16.3 BenevolentAI Artificial Intelligence-driven Drug Development Product Market Performance
9.16.4 BenevolentAI Business Overview
9.16.5 BenevolentAI Recent Developments
9.17 Cyclica
9.17.1 Cyclica Artificial Intelligence-driven Drug Development Basic Information
9.17.2 Cyclica Artificial Intelligence-driven Drug Development Product Overview
9.17.3 Cyclica Artificial Intelligence-driven Drug Development Product Market Performance
9.17.4 Cyclica Business Overview
9.17.5 Cyclica Recent Developments
9.18 Verge Genomics
9.18.1 Verge Genomics Artificial Intelligence-driven Drug Development Basic Information
9.18.2 Verge Genomics Artificial Intelligence-driven Drug Development Product Overview
9.18.3 Verge Genomics Artificial Intelligence-driven Drug Development Product Market Performance
9.18.4 Verge Genomics Business Overview
9.18.5 Verge Genomics Recent Developments
9.19 Valo Health
9.19.1 Valo Health Artificial Intelligence-driven Drug Development Basic Information
9.19.2 Valo Health Artificial Intelligence-driven Drug Development Product Overview
9.19.3 Valo Health Artificial Intelligence-driven Drug Development Product Market Performance
9.19.4 Valo Health Business Overview
9.19.5 Valo Health Recent Developments
9.20 Envisagenics
9.20.1 Envisagenics Artificial Intelligence-driven Drug Development Basic Information
9.20.2 Envisagenics Artificial Intelligence-driven Drug Development Product Overview
9.20.3 Envisagenics Artificial Intelligence-driven Drug Development Product Market Performance
9.20.4 Envisagenics Business Overview
9.20.5 Envisagenics Recent Developments
9.21 Euretos
9.21.1 Euretos Artificial Intelligence-driven Drug Development Basic Information
9.21.2 Euretos Artificial Intelligence-driven Drug Development Product Overview
9.21.3 Euretos Artificial Intelligence-driven Drug Development Product Market Performance
9.21.4 Euretos Business Overview
9.21.5 Euretos Recent Developments
9.22 BioAge Labs
9.22.1 BioAge Labs Artificial Intelligence-driven Drug Development Basic Information
9.22.2 BioAge Labs Artificial Intelligence-driven Drug Development Product Overview
9.22.3 BioAge Labs Artificial Intelligence-driven Drug Development Product Market Performance
9.22.4 BioAge Labs Business Overview
9.22.5 BioAge Labs Recent Developments
9.23 Iktos
9.23.1 Iktos Artificial Intelligence-driven Drug Development Basic Information
9.23.2 Iktos Artificial Intelligence-driven Drug Development Product Overview
9.23.3 Iktos Artificial Intelligence-driven Drug Development Product Market Performance
9.23.4 Iktos Business Overview
9.23.5 Iktos Recent Developments
9.24 BioSymetrics
9.24.1 BioSymetrics Artificial Intelligence-driven Drug Development Basic Information
9.24.2 BioSymetrics Artificial Intelligence-driven Drug Development Product Overview
9.24.3 BioSymetrics Artificial Intelligence-driven Drug Development Product Market Performance
9.24.4 BioSymetrics Business Overview
9.24.5 BioSymetrics Recent Developments
9.25 Evaxion Biotech
9.25.1 Evaxion Biotech Artificial Intelligence-driven Drug Development Basic Information
9.25.2 Evaxion Biotech Artificial Intelligence-driven Drug Development Product Overview
9.25.3 Evaxion Biotech Artificial Intelligence-driven Drug Development Product Market Performance
9.25.4 Evaxion Biotech Business Overview
9.25.5 Evaxion Biotech Recent Developments
9.26 Aria Pharmaceuticals
9.26.1 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Basic Information
9.26.2 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Product Overview
9.26.3 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Product Market Performance
9.26.4 Aria Pharmaceuticals Business Overview
9.26.5 Aria Pharmaceuticals Recent Developments
10 Artificial Intelligence-driven Drug Development Regional Market Forecast
10.1 Global Artificial Intelligence-driven Drug Development Market Size Forecast
10.2 Global Artificial Intelligence-driven Drug Development Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Artificial Intelligence-driven Drug Development Market Size Forecast by Country
10.2.3 Asia Pacific Artificial Intelligence-driven Drug Development Market Size Forecast by Region
10.2.4 South America Artificial Intelligence-driven Drug Development Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Artificial Intelligence-driven Drug Development by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Artificial Intelligence-driven Drug Development Market Forecast by Type (2025-2030)
11.2 Global Artificial Intelligence-driven Drug Development Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Artificial Intelligence-driven Drug Development Market Size Comparison by Region (M USD)
Table 5. Global Artificial Intelligence-driven Drug Development Revenue (M USD) by Company (2019-2024)
Table 6. Global Artificial Intelligence-driven Drug Development Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence-driven Drug Development as of 2022)
Table 8. Company Artificial Intelligence-driven Drug Development Market Size Sites and Area Served
Table 9. Company Artificial Intelligence-driven Drug Development Product Type
Table 10. Global Artificial Intelligence-driven Drug Development Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Artificial Intelligence-driven Drug Development
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Artificial Intelligence-driven Drug Development Market Challenges
Table 18. Global Artificial Intelligence-driven Drug Development Market Size by Type (M USD)
Table 19. Global Artificial Intelligence-driven Drug Development Market Size (M USD) by Type (2019-2024)
Table 20. Global Artificial Intelligence-driven Drug Development Market Size Share by Type (2019-2024)
Table 21. Global Artificial Intelligence-driven Drug Development Market Size Growth Rate by Type (2019-2024)
Table 22. Global Artificial Intelligence-driven Drug Development Market Size by Application
Table 23. Global Artificial Intelligence-driven Drug Development Market Size by Application (2019-2024) & (M USD)
Table 24. Global Artificial Intelligence-driven Drug Development Market Share by Application (2019-2024)
Table 25. Global Artificial Intelligence-driven Drug Development Market Size Growth Rate by Application (2019-2024)
Table 26. Global Artificial Intelligence-driven Drug Development Market Size by Region (2019-2024) & (M USD)
Table 27. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Region (2019-2024)
Table 28. North America Artificial Intelligence-driven Drug Development Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Artificial Intelligence-driven Drug Development Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Artificial Intelligence-driven Drug Development Market Size by Region (2019-2024) & (M USD)
Table 31. South America Artificial Intelligence-driven Drug Development Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Artificial Intelligence-driven Drug Development Market Size by Region (2019-2024) & (M USD)
Table 33. IBM Artificial Intelligence-driven Drug Development Basic Information
Table 34. IBM Artificial Intelligence-driven Drug Development Product Overview
Table 35. IBM Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 36. IBM Artificial Intelligence-driven Drug Development SWOT Analysis
Table 37. IBM Business Overview
Table 38. IBM Recent Developments
Table 39. Exscientia Artificial Intelligence-driven Drug Development Basic Information
Table 40. Exscientia Artificial Intelligence-driven Drug Development Product Overview
Table 41. Exscientia Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 42. IBM Artificial Intelligence-driven Drug Development SWOT Analysis
Table 43. Exscientia Business Overview
Table 44. Exscientia Recent Developments
Table 45. Google(Alphabet) Artificial Intelligence-driven Drug Development Basic Information
Table 46. Google(Alphabet) Artificial Intelligence-driven Drug Development Product Overview
Table 47. Google(Alphabet) Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 48. IBM Artificial Intelligence-driven Drug Development SWOT Analysis
Table 49. Google(Alphabet) Business Overview
Table 50. Google(Alphabet) Recent Developments
Table 51. Microsoft Artificial Intelligence-driven Drug Development Basic Information
Table 52. Microsoft Artificial Intelligence-driven Drug Development Product Overview
Table 53. Microsoft Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Microsoft Business Overview
Table 55. Microsoft Recent Developments
Table 56. Atomwise Artificial Intelligence-driven Drug Development Basic Information
Table 57. Atomwise Artificial Intelligence-driven Drug Development Product Overview
Table 58. Atomwise Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Atomwise Business Overview
Table 60. Atomwise Recent Developments
Table 61. Schrodinger Artificial Intelligence-driven Drug Development Basic Information
Table 62. Schrodinger Artificial Intelligence-driven Drug Development Product Overview
Table 63. Schrodinger Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Schrodinger Business Overview
Table 65. Schrodinger Recent Developments
Table 66. Aitia Artificial Intelligence-driven Drug Development Basic Information
Table 67. Aitia Artificial Intelligence-driven Drug Development Product Overview
Table 68. Aitia Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Aitia Business Overview
Table 70. Aitia Recent Developments
Table 71. Insilico Medicine Artificial Intelligence-driven Drug Development Basic Information
Table 72. Insilico Medicine Artificial Intelligence-driven Drug Development Product Overview
Table 73. Insilico Medicine Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Insilico Medicine Business Overview
Table 75. Insilico Medicine Recent Developments
Table 76. NVIDIA Artificial Intelligence-driven Drug Development Basic Information
Table 77. NVIDIA Artificial Intelligence-driven Drug Development Product Overview
Table 78. NVIDIA Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 79. NVIDIA Business Overview
Table 80. NVIDIA Recent Developments
Table 81. XtalPi Artificial Intelligence-driven Drug Development Basic Information
Table 82. XtalPi Artificial Intelligence-driven Drug Development Product Overview
Table 83. XtalPi Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 84. XtalPi Business Overview
Table 85. XtalPi Recent Developments
Table 86. BPGbio Artificial Intelligence-driven Drug Development Basic Information
Table 87. BPGbio Artificial Intelligence-driven Drug Development Product Overview
Table 88. BPGbio Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 89. BPGbio Business Overview
Table 90. BPGbio Recent Developments
Table 91. Owkin Artificial Intelligence-driven Drug Development Basic Information
Table 92. Owkin Artificial Intelligence-driven Drug Development Product Overview
Table 93. Owkin Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 94. Owkin Business Overview
Table 95. Owkin Recent Developments
Table 96. CytoReason Artificial Intelligence-driven Drug Development Basic Information
Table 97. CytoReason Artificial Intelligence-driven Drug Development Product Overview
Table 98. CytoReason Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 99. CytoReason Business Overview
Table 100. CytoReason Recent Developments
Table 101. Deep Genomics Artificial Intelligence-driven Drug Development Basic Information
Table 102. Deep Genomics Artificial Intelligence-driven Drug Development Product Overview
Table 103. Deep Genomics Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 104. Deep Genomics Business Overview
Table 105. Deep Genomics Recent Developments
Table 106. Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Basic Information
Table 107. Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Product Overview
Table 108. Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 109. Cloud Pharmaceuticals Business Overview
Table 110. Cloud Pharmaceuticals Recent Developments
Table 111. BenevolentAI Artificial Intelligence-driven Drug Development Basic Information
Table 112. BenevolentAI Artificial Intelligence-driven Drug Development Product Overview
Table 113. BenevolentAI Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 114. BenevolentAI Business Overview
Table 115. BenevolentAI Recent Developments
Table 116. Cyclica Artificial Intelligence-driven Drug Development Basic Information
Table 117. Cyclica Artificial Intelligence-driven Drug Development Product Overview
Table 118. Cyclica Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 119. Cyclica Business Overview
Table 120. Cyclica Recent Developments
Table 121. Verge Genomics Artificial Intelligence-driven Drug Development Basic Information
Table 122. Verge Genomics Artificial Intelligence-driven Drug Development Product Overview
Table 123. Verge Genomics Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 124. Verge Genomics Business Overview
Table 125. Verge Genomics Recent Developments
Table 126. Valo Health Artificial Intelligence-driven Drug Development Basic Information
Table 127. Valo Health Artificial Intelligence-driven Drug Development Product Overview
Table 128. Valo Health Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 129. Valo Health Business Overview
Table 130. Valo Health Recent Developments
Table 131. Envisagenics Artificial Intelligence-driven Drug Development Basic Information
Table 132. Envisagenics Artificial Intelligence-driven Drug Development Product Overview
Table 133. Envisagenics Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 134. Envisagenics Business Overview
Table 135. Envisagenics Recent Developments
Table 136. Euretos Artificial Intelligence-driven Drug Development Basic Information
Table 137. Euretos Artificial Intelligence-driven Drug Development Product Overview
Table 138. Euretos Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 139. Euretos Business Overview
Table 140. Euretos Recent Developments
Table 141. BioAge Labs Artificial Intelligence-driven Drug Development Basic Information
Table 142. BioAge Labs Artificial Intelligence-driven Drug Development Product Overview
Table 143. BioAge Labs Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 144. BioAge Labs Business Overview
Table 145. BioAge Labs Recent Developments
Table 146. Iktos Artificial Intelligence-driven Drug Development Basic Information
Table 147. Iktos Artificial Intelligence-driven Drug Development Product Overview
Table 148. Iktos Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 149. Iktos Business Overview
Table 150. Iktos Recent Developments
Table 151. BioSymetrics Artificial Intelligence-driven Drug Development Basic Information
Table 152. BioSymetrics Artificial Intelligence-driven Drug Development Product Overview
Table 153. BioSymetrics Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 154. BioSymetrics Business Overview
Table 155. BioSymetrics Recent Developments
Table 156. Evaxion Biotech Artificial Intelligence-driven Drug Development Basic Information
Table 157. Evaxion Biotech Artificial Intelligence-driven Drug Development Product Overview
Table 158. Evaxion Biotech Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 159. Evaxion Biotech Business Overview
Table 160. Evaxion Biotech Recent Developments
Table 161. Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Basic Information
Table 162. Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Product Overview
Table 163. Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue (M USD) and Gross Margin (2019-2024)
Table 164. Aria Pharmaceuticals Business Overview
Table 165. Aria Pharmaceuticals Recent Developments
Table 166. Global Artificial Intelligence-driven Drug Development Market Size Forecast by Region (2025-2030) & (M USD)
Table 167. North America Artificial Intelligence-driven Drug Development Market Size Forecast by Country (2025-2030) & (M USD)
Table 168. Europe Artificial Intelligence-driven Drug Development Market Size Forecast by Country (2025-2030) & (M USD)
Table 169. Asia Pacific Artificial Intelligence-driven Drug Development Market Size Forecast by Region (2025-2030) & (M USD)
Table 170. South America Artificial Intelligence-driven Drug Development Market Size Forecast by Country (2025-2030) & (M USD)
Table 171. Middle East and Africa Artificial Intelligence-driven Drug Development Market Size Forecast by Country (2025-2030) & (M USD)
Table 172. Global Artificial Intelligence-driven Drug Development Market Size Forecast by Type (2025-2030) & (M USD)
Table 173. Global Artificial Intelligence-driven Drug Development Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Industrial Chain of Artificial Intelligence-driven Drug Development
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Artificial Intelligence-driven Drug Development Market Size (M USD), 2019-2030
Figure 5. Global Artificial Intelligence-driven Drug Development Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Artificial Intelligence-driven Drug Development Market Size by Country (M USD)
Figure 10. Global Artificial Intelligence-driven Drug Development Revenue Share by Company in 2023
Figure 11. Artificial Intelligence-driven Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Artificial Intelligence-driven Drug Development Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Artificial Intelligence-driven Drug Development Market Share by Type
Figure 15. Market Size Share of Artificial Intelligence-driven Drug Development by Type (2019-2024)
Figure 16. Market Size Market Share of Artificial Intelligence-driven Drug Development by Type in 2022
Figure 17. Global Artificial Intelligence-driven Drug Development Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Artificial Intelligence-driven Drug Development Market Share by Application
Figure 20. Global Artificial Intelligence-driven Drug Development Market Share by Application (2019-2024)
Figure 21. Global Artificial Intelligence-driven Drug Development Market Share by Application in 2022
Figure 22. Global Artificial Intelligence-driven Drug Development Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Region (2019-2024)
Figure 24. North America Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Artificial Intelligence-driven Drug Development Market Size Market Share by Country in 2023
Figure 26. U.S. Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Artificial Intelligence-driven Drug Development Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Artificial Intelligence-driven Drug Development Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Country in 2023
Figure 31. Germany Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Artificial Intelligence-driven Drug Development Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Artificial Intelligence-driven Drug Development Market Size Market Share by Region in 2023
Figure 38. China Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Artificial Intelligence-driven Drug Development Market Size and Growth Rate (M USD)
Figure 44. South America Artificial Intelligence-driven Drug Development Market Size Market Share by Country in 2023
Figure 45. Brazil Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Artificial Intelligence-driven Drug Development Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Artificial Intelligence-driven Drug Development Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Artificial Intelligence-driven Drug Development Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Artificial Intelligence-driven Drug Development Market Share Forecast by Type (2025-2030)
Figure 57. Global Artificial Intelligence-driven Drug Development Market Share Forecast by Application (2025-2030)
Industry Market Size
